PKCδ serves as a potential biomarker and therapeutic target for microglia‐mediated neuroinflammation in Alzheimer's disease - Du, Ying; Guo, Tiantian; Hao, Yunfeng; Li, Chuan; Tang, Linghui; Li, Xia; Zhang, Xiaoxiao; Li, Lin; Yao, Dan; Xu, Xia; Si, Huaxing; Zhang, Jinghan; et al. (Alzheimer's & dementia, 2024)
Keywords: Aged; Alzheimer Disease; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-Peptides - metabolism; Animals; Biomarkers - cerebrospinal fluid; Cytokines - cerebrospinal fluid; Cytokines - metabolism; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; microglia; Microglia - metabolism; neuroinflammation; Neuroinflammatory Diseases - drug therapy; NF-kappa B - metabolism; NF‐κB; PKCδ; Protein Kinase C-delta - metabolism; PKCδ; NF‐κB; neuroinflammation; Alzheimer's disease; microglia